|
CBWD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.479600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.699600E-02 |
| Normal-vs-Stage2 |
1.784020E-01 |
| Normal-vs-Stage3 |
1.345580E-01 |
| Normal-vs-Stage4 |
6.748200E-02 |
| Stage1-vs-Stage2 |
5.455600E-01 |
| Stage1-vs-Stage3 |
6.585800E-01 |
| Stage1-vs-Stage4 |
7.485400E-01 |
| Stage2-vs-Stage3 |
8.629400E-01 |
| Stage2-vs-Stage4 |
4.414400E-01 |
| Stage3-vs-Stage4 |
5.910000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.229580E-01 |
| Normal-vs-AfricanAmerican |
4.790200E-04 |
| Normal-vs-Asian |
1.557970E-02 |
| Caucasian-vs-AfricanAmerican |
9.184300E-03 |
| Caucasian-vs-Asian |
1.163570E-01 |
| AfricanAmerican-vs-Asian |
2.034000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.619600E-02 |
| Normal-vs-Female |
1.723040E-03 |
| Male-vs-Female |
8.433800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.018200E-01 |
| Normal-vs-Extreme_Weight |
1.234030E-02 |
| Normal-vs-Obese |
3.687500E-02 |
| Normal-vs-Extreme_Obese |
3.449600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.226200E-01 |
| Normal_Weight-vs-Obese |
5.612800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.550000E-01 |
| Extreme_Weight-vs-Obese |
7.898600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.291800E-01 |
| Obese-vs-Extreme_Obese |
6.541400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.894000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.741700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.876400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.345000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.888400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.815000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.615430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.065000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.988500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.537800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.880300E-03 |
| Normal-VS-Type2 PRCC |
2.381200E-01 |
| Normal-VS-KIRP CIMP |
1.508280E-02 |
| Normal-VS-Unclassified PRCC |
2.243700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.235600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.220600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.320400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.001700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.149400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.377200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.170000E-01 |
| Normal-vs-N1 |
1.394390E-01 |
| Normal-vs-N2 |
9.150300E-02 |
| N0-vs-N1 |
4.055600E-01 |
| N0-vs-N2 |
2.801000E-01 |
| N1-vs-N2 |
4.624000E-01 |
|
|
